Atlas FDA

Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account

MYI — Predicate Candidate Screening

10 FDA 510(k) clearances under this product code; the 50 most recent screened below.

252 daysmedian FDA review time
432 days90th percentile
10clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K140619MECA XPRESSFISHAdvandx, Inc.2014-10-102130
K133851ALERE PBP2A SA/CONS CULTURE COLONY TESTAlere Scarborough, Inc.2014-09-032580
K121905ALERE PBP2A TESTAlere Scarborough, Inc.2012-07-26270
K090301BINAXNOW PBP2A TEST, MODEL 890-000Binax, Inc.2010-04-144320
K091766CLEARVIEW EXACT PBP2A TEST, MODEL 891-000Binax, Inc.2010-02-242520
K062864MASTALEX -MRSA, MODEL RST501Mast Group , Ltd.2006-10-18230
K011710OXOID PBP2 1 LATEX AGGLUTINATION TESTOxoid , Ltd.2002-04-023020
K011400MRSA-SCREENDenka Seiken'S2002-03-273240
K010858VELOGENE GENOMIC IDENTIFICATION ASSAY FOR MRSA WITH ONE-STEPId Biomedical Corp.2001-05-24630
K990640VELOGENE RAPID MRSA IDENTIFICATION ASSAYId Biomedical Corp.1999-07-091330

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda